A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment
Clinical trial NCT03425552 · COMPLETED
Trial details
- NCT number
- NCT03425552
- Sponsor
- Pharmathen S.A.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-11
- Primary completion
- 2019-05-02
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.